Stockscreener 앱 받기
108.20
0.75%
-0.82
시장 영업 전:
108.20
전일 마감가:
$109.02
열려 있는:
$109.2
하루 거래량:
13.16M
Relative Volume:
1.62
시가총액:
$188.15B
수익:
$44.33B
순이익/손실:
$6.48B
주가수익비율:
29.22
EPS:
3.7033
순현금흐름:
$6.92B
1주 성능:
+2.03%
1개월 성능:
-12.88%
6개월 성능:
-16.72%
1년 성능:
-16.19%
1일 변동 폭
$107.64
$109.73
1주일 범위
$105.34
$111.00
52주 변동 폭
$105.27
$140.84
애보트 래버러토리스 Stock (ABT) Company Profile
명칭
Abbott Laboratories
전화
(224) 667-6100
주소
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
ABT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABT
Abbott Laboratories
|
108.20 | 189.57B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
360.66 | 137.99B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
101.84 | 132.28B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
75.50 | 135.87B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
EW
Edwards Lifesciences Corp
|
79.77 | 47.64B | 5.88B | 1.34B | 799.60M | 2.3489 |
애보트 래버러토리스 Stock (ABT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-10 | 개시 | The Benchmark Company | Buy |
| 2025-07-18 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-06-16 | 개시 | Leerink Partners | Market Perform |
| 2024-10-08 | 개시 | Oppenheimer | Outperform |
| 2024-09-19 | 개시 | Piper Sandler | Overweight |
| 2024-07-30 | 다운그레이드 | Edward Jones | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-07-21 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2023-05-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-04-20 | 재확인 | Barclays | Overweight |
| 2023-04-20 | 재확인 | Bernstein | Outperform |
| 2023-04-20 | 재확인 | JP Morgan | Overweight |
| 2023-04-20 | 재확인 | Raymond James | Outperform |
| 2023-04-20 | 재확인 | UBS | Buy |
| 2023-04-20 | 재확인 | Wolfe Research | Underperform |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-10-26 | 개시 | Mizuho | Neutral |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-06 | 개시 | Wolfe Research | Underperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-01-27 | 재확인 | Credit Suisse | Outperform |
| 2022-01-27 | 재확인 | Morgan Stanley | Overweight |
| 2022-01-27 | 재확인 | Raymond James | Outperform |
| 2022-01-27 | 재확인 | UBS | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-10-27 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2021-10-14 | 개시 | Redburn | Neutral |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Neutral |
| 2021-01-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-06-01 | 다운그레이드 | Goldman | Neutral → Sell |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Neutral |
| 2020-01-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-06-13 | 재확인 | BofA/Merrill | Buy |
| 2019-02-07 | 재확인 | BofA/Merrill | Buy |
| 2019-01-02 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2018-11-30 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-01-30 | 재확인 | Citigroup | Neutral |
| 2018-01-25 | 재확인 | Stifel | Buy |
| 2018-01-25 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2018-01-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-01-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2017-10-19 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-10-19 | 재확인 | Stifel | Buy |
모두보기
애보트 래버러토리스 주식(ABT)의 최신 뉴스
US FDA says injuries from Abbott’s recalled glucose sensors reach 860 - WHTC
US FDA says injuries from Abbott's recalled glucose sensors reach 860 - marketscreener.com
Abbott recalls glucose sensors after seven deaths linked to faulty readings - marketscreener.com
Abbott Laboratories (ABT) Faces FDA's Most Serious Recall Over G - GuruFocus
Abbott glucose monitor recall classified as most serious (ABT) - Seeking Alpha
Do Wall Street Analysts Like Abbott Laboratories Stock? - Yahoo Finance
FDA demands better response from Abbott over Libre inspection violations - Fierce Biotech
Hantz Financial Services Inc. Sells 29,746 Shares of Abbott Laboratories $ABT - MarketBeat
Envestnet Asset Management Inc. Sells 169,808 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories Stock Now 18% Cheaper, Time To Buy - Trefis
Gains Report: Can Abbott Laboratories sustain earnings growthDay Trade & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Abbott receives FDA warning letter related to FreeStyle Libre CGMs - MassDevice
2 Healthcare Dividend Stocks That are Just What the Doctor Ordered - The Motley Fool
Abbott Faces FDA Scrutiny On FreeStyle Libre And Broader Quality Story - Yahoo Finance
Abbott (ABT) stock slips on FDA warning letter over FreeStyle Libre testing; dates to watch - TechStock²
Abbott CEO Share Purchase Highlights $21b Exact Sciences Deal And Valuation - simplywall.st
Abbott receives FDA warning letter over Freestyle Libre CGMs - MedTech Dive
Abbott (ABT) Faces Profit Headwinds as Pediatric Nutrition Remains Under Pressure - Finviz
OTC/DTC Infectious Disease Diagnostics Research Report 2026: Market Strategies, Trends, and Forecasts 2025-2029 - GlobeNewswire Inc.
Sollinda Capital Management LLC Sells 15,866 Shares of Abbott Laboratories $ABT - MarketBeat
Jones Financial Companies Lllp Buys 61,627 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Stake Lessened by Thrivent Financial for Lutherans - MarketBeat
Abbott Laboratories (ABT): A Bull Case Theory - Insider Monkey
Abbott Labs CEO makes $2M bet as stock sinks - thestreet.com
Abbott (ABT) Sees Increased Bearish Options Activity - GuruFocus
Abbott (ABT) stock price steadies after Barclays trims target; Exact Sciences vote is next key date - TechStock²
Abbott’s Exact Sciences Deal Recasts Diagnostics While Nutrition Faces Reset - Yahoo Finance
Abbott stock price today: ABT slips after Barclays cuts target as Wall Street resets expectations - TechStock²
The Best Dividend King to Buy With $150 - AOL.com
ABT: Barclays Adjusts Abbott Laboratories Price Target to $142 | - GuruFocus
Abbott Laboratories (NYSE:ABT) Price Target Cut to $142.00 by Analysts at Barclays - MarketBeat
Abbott: Long-Term Investment Opportunity For Dividend Growth Investors - Seeking Alpha
Barclays Cuts Price Target on Abbott Laboratories to $142 From $169, Maintains Overweight Rating - marketscreener.com
Abbott has 2-year data supporting Tendyne mitral valve replacement - MassDevice
Mawer Investment Management Ltd. Has $168.20 Million Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Barclays Maintains Abbott Laboratories(ABT.US) With Buy Rating, Cuts Target Price to $142 - 富途牛牛
Abbott stock price rebounds 3% after Friday rally as analysts cut targets; what’s next for ABT - TechStock²
Assessing Abbott Laboratories (ABT) Valuation After Q4 Nutrition Weakness And Ongoing Device Strength - simplywall.st
Decent organic sales growth expected for Abbott Laboratories (ABT) in 2026 - MSN
Principal Financial Group Inc. Sells 331,362 Shares of Abbott Laboratories $ABT - MarketBeat
Mediolanum International Funds Ltd Acquires 169,026 Shares of Abbott Laboratories $ABT - MarketBeat
Freedom Capital Upgrades Abbott Laboratories (ABT) to Buy - Finviz
Looking for Passive Income in 2026? 3 Dividend Kings to Buy Hand Over Fist - Finviz
Abbott Laboratories stock price: ABT ends Friday up 3% — what investors watch next week - TechStock²
Abbott Clears Major Hurdle in $21 Billion Exact Sciences Acquisition - AD HOC NEWS
Abbott Laboratories Resets Portfolio With Exact Sciences Cancer Diagnostics Deal - Yahoo Finance
Abbott Laboratories (NYSE:ABT) Price Target Cut to $119.00 by Analysts at Leerink Partners - MarketBeat
Daiwa Capital Markets Has Lowered Expectations for Abbott Laboratories (NYSE:ABT) Stock Price - MarketBeat
Abbott Laboratories (NYSE:ABT) Rating Increased to Strong-Buy at Freedom Capital - MarketBeat
Applied Digital, Goldman Sachs, UPS, Abbott, Schlumberger Shake-Up - TipRanks
Private Wealth Partners LLC Purchases 12,025 Shares of Abbott Laboratories $ABT - MarketBeat
애보트 래버러토리스 (ABT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.04%
4.89%
자본화:
|
볼륨(24시간):